| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/20/2011 | WO2009150630A3 Compositions of carbon dioxide adduct of ertapenem and polymorphic forms of ertapenem monosodium salt |
| 01/20/2011 | WO2009146490A8 A method for increasing bone density and/or reducing any osteochondral defects in an animal and a composition including vitamin k |
| 01/20/2011 | WO2009004595A3 Enhancement of the efficacy of therapeutic proteins |
| 01/20/2011 | WO2007093409A8 Mcp-i binding nucleic acids |
| 01/20/2011 | WO2006097924A8 Cyclic phosphates as plant growth regulators |
| 01/20/2011 | US20110016544 Methods and compositions for detecting and treating retinal diseases based on metargidin (ADAM-15) |
| 01/20/2011 | US20110016538 Susceptibility locus for schizophrenia |
| 01/20/2011 | US20110015663 Combination Therapies for the Treatment of Obesity |
| 01/20/2011 | US20110015586 Application of polymeric materials to screens to facilitate hemostasis and wound healing |
| 01/20/2011 | US20110015437 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 01/20/2011 | US20110015408 Sulfonylpyrrolidine modulators of androgen receptor function and method |
| 01/20/2011 | US20110015395 Pyrazole compounds with inhibitory activity against ros kinase |
| 01/20/2011 | US20110015344 Biodegradable polyacetals for in vivo polynucleotide delivery |
| 01/20/2011 | US20110015278 Phytol as a cholesterol lowering agent |
| 01/20/2011 | US20110015277 Method of producing egg yolk based functional food product and products obtainable thereby |
| 01/20/2011 | US20110015276 Therapeutical uses of inecalcitol |
| 01/20/2011 | US20110015275 Materials and Methods for Improving Alcohol Metabolism and Alleviating the Effects of Hangovers |
| 01/20/2011 | US20110015274 Form of an aminoindan mesylate derivative |
| 01/20/2011 | US20110015273 Stable pharmaceutical aqueous compositions |
| 01/20/2011 | US20110015272 Sirtuin 1 and the Treatment of Neurodegenerative Diseases |
| 01/20/2011 | US20110015271 Topical nepafenac formulations |
| 01/20/2011 | US20110015270 Novel NIDDM Regimen |
| 01/20/2011 | US20110015269 Process for the preparation of diacerin |
| 01/20/2011 | US20110015268 Pharmaceutical composition |
| 01/20/2011 | US20110015267 Methods for the preparation and use of aqueous solutions of magnesium valproate hydrate and l-carnitine |
| 01/20/2011 | US20110015266 Lyophilized nanoemulsion |
| 01/20/2011 | US20110015264 Intramuscular antiviral treatments |
| 01/20/2011 | US20110015263 Therapeutic delivery of carbon monoxide |
| 01/20/2011 | US20110015262 Systems and methods for treating human inflammatory and proliferative diseases, with a combination of compounds, or a bifunctional compound, that provides fatty acid metabolism and glycolysis inhibition |
| 01/20/2011 | US20110015261 Use of a composition comprising at least one beta-blocker for the treatment of sleep disorders |
| 01/20/2011 | US20110015260 Anti-malarial pharmaceutical composition |
| 01/20/2011 | US20110015259 Tle3 as a marker for chemotherapy |
| 01/20/2011 | US20110015258 Antisense oligonucleotides for inducing exon skipping and methods of use thereof |
| 01/20/2011 | US20110015257 Hypoxia Inducible VEGF Plasmid for Ischemic Disease |
| 01/20/2011 | US20110015256 Delivery of restriction endonucleases to treat hiv, cancer, and other medical conditions |
| 01/20/2011 | US20110015255 Treatment of an infection by an rna virus due to an rna dependent rna polymerase |
| 01/20/2011 | US20110015254 PTPH1 Inhibitors for the Treatment of Alzheimer's Disease |
| 01/20/2011 | US20110015252 Lipid formulated dsrna targeting the pcsk9 gene |
| 01/20/2011 | US20110015251 RNA INTERFERENCE MEDIATED INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 01/20/2011 | US20110015250 COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 GENE |
| 01/20/2011 | US20110015249 Methods and compositions for treatment of cancer and other angiogenesis-related diseases |
| 01/20/2011 | US20110015248 Substituted heterocycles |
| 01/20/2011 | US20110015247 Novel crystalline form of carvedilol dihydrogen phosphate and related processes |
| 01/20/2011 | US20110015246 Lofexidine enantiomers for use as a treatment for cns disease and pathologies and its chiral synthesis |
| 01/20/2011 | US20110015245 Bendamustine amphiphilic cationic compositions |
| 01/20/2011 | US20110015244 Bendamustine amphiphilic anionic compositions |
| 01/20/2011 | US20110015243 Co-solvent compositions and methods for improved delivery of dantrolene theraputic agents |
| 01/20/2011 | US20110015242 Pdk-1/akt signaling inhibitors |
| 01/20/2011 | US20110015241 Substituted heterocycles and use thereof |
| 01/20/2011 | US20110015240 Thiazole derivative and use thereof as vap-1 inhibitor |
| 01/20/2011 | US20110015239 Inhibitors of calcium-activated chloride channels |
| 01/20/2011 | US20110015238 Blood flow promoters for cauda equina tissues |
| 01/20/2011 | US20110015235 Novel phenylethynyl derivatives of 8-aza-bicyclo[3.2.1]octane and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/20/2011 | US20110015234 Indazole derivatives |
| 01/20/2011 | US20110015233 Stable Pharmaceutical Omeprazole Formulation for Oral Administration |
| 01/20/2011 | US20110015232 Pyrrolydine Derivatives as IAP Inhibitors |
| 01/20/2011 | US20110015231 Isoxazole and isothiazole compounds useful in the treatment of inflammation |
| 01/20/2011 | US20110015230 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same |
| 01/20/2011 | US20110015229 Method of treating neuropathic pain |
| 01/20/2011 | US20110015228 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 01/20/2011 | US20110015227 Warming sensate composition |
| 01/20/2011 | US20110015226 Treatment of Energy Utilization Disease |
| 01/20/2011 | US20110015225 Heterocyclic compound |
| 01/20/2011 | US20110015224 Combination of a carbostyril and carnitine |
| 01/20/2011 | US20110015223 Compounds and methods for treatment of cancer-related anemia |
| 01/20/2011 | US20110015222 Benzoquinolizinium salt derivatives as anticancer agents |
| 01/20/2011 | US20110015221 Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same |
| 01/20/2011 | US20110015220 Mixed orl1/mu-agonists for the treatment of pain |
| 01/20/2011 | US20110015219 (+)-Morphinans as Antagonists of Toll-Like Receptor 9 and Therapeutic Uses Thereof |
| 01/20/2011 | US20110015218 Aza-bicyclohexyl substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
| 01/20/2011 | US20110015217 Pro-Neurogenic Compounds |
| 01/20/2011 | US20110015216 Solid Pharmaceutical Dosage Form |
| 01/20/2011 | US20110015215 Crystalline forms of 4-[6-(6-methanesulfonyl-2-methyl-pyridin-3-ylamino)-5-methoxy-pyrimidin-4-yloxy]-piperidine-1-carboxylic acid isopropyl ester |
| 01/20/2011 | US20110015214 Tricyclic benzo[4,5]thieno-[2,3-d]pyrimidine-4-yl-amin derivatives, their salts, process for producing the compounds and their pharmaceutical use |
| 01/20/2011 | US20110015213 Quinazoline derivatives |
| 01/20/2011 | US20110015212 Pyrimidinones as pi3k inhibitors |
| 01/20/2011 | US20110015211 Fibrosis inhibitor |
| 01/20/2011 | US20110015210 Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 01/20/2011 | US20110015209 Sigma ligands for neuronal regeneration and functional recovery |
| 01/20/2011 | US20110015208 Pharmaceutical compositions containing dopamine receptor ligands and methods of treatment using dopamine receptor ligands |
| 01/20/2011 | US20110015207 Sulfated benzimidazolone derivatives having mixed serotonine receptor affinity |
| 01/20/2011 | US20110015206 Method of stabilizing lipid-rich plaque and method of preventing rupture thereof |
| 01/20/2011 | US20110015205 Trazodone Composition for Once a Day Administration |
| 01/20/2011 | US20110015204 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 01/20/2011 | US20110015203 Viral Polymerase Inhibitors |
| 01/20/2011 | US20110015202 Imidazoles |
| 01/20/2011 | US20110015201 Hedgehog pathway antagonists and methods of use |
| 01/20/2011 | US20110015200 Nitrogen-containing bycyclic compounds active on chronic pain conditions |
| 01/20/2011 | US20110015199 GPR119 Agonists |
| 01/20/2011 | US20110015198 Diarylmethylamide derivative having melanin-concentrating hormone receptor antagonism |
| 01/20/2011 | US20110015197 mTOR INHIBITOR SALT FORMS |
| 01/20/2011 | US20110015196 Lupeol-type triterpene derivatives as antivirals |
| 01/20/2011 | US20110015195 Aryl ureas with angiogenisis inhibiting activity |
| 01/20/2011 | US20110015194 Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 01/20/2011 | US20110015193 1, 5-dihydro-pyrazolo (3, 4-d) pyrimidin-4-one derivatives and their use as pde9a mudulators for the treatment of cns disorders |
| 01/20/2011 | US20110015192 Sirtuin modulating compounds |
| 01/20/2011 | US20110015191 Organic compounds |
| 01/20/2011 | US20110015190 Gamma secretase modulators |
| 01/20/2011 | US20110015189 Methods of making efavirenz and intermediates thereof |
| 01/20/2011 | US20110015188 Treatment of Seasonal Conditions |